Tech Company Inital Public Offerings
Cytek Biosciences IPO
Cytek Biosciences, based in Fremont, had an IPO event on 7/23/2021.
Transaction Overview
Company Name
Announced On
7/23/2021
Transaction Type
IPO
Amount
$248,200,000
Proceeds Purpose
Use of proceeds for the Cytek Biosciences IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
46107 Landing Pkwy.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek's compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wenbin Jiang
Chief Financial Officer
Patrik Jeanmonod
Chief Technical Officer
Ming Yan
General Manager
Ken Riley
VP - Marketing
Mark Herberger
VP - Marketing
Gil Reinin
VP - Sales
Ray Lannigan
VP - Sales
Steve Ziganti
Browse more venture capital transactions:
Prev: 7/22/2021: DNSFilter venture capital transaction
Next: 7/23/2021: CloudTruth venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs